Avoid stacking DSIP with other sedating compounds, alcohol, or prescription sleep medications
Retatrutide works like semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) to promote weight loss, but it acts at three receptors at once and exerts the following actions: GLP-1 receptor agonism As a glucagon-like peptide-1 (GLP-1) receptor agonist, retatrutide has the following effects: The medication increases insulin secretion and reduces glucagon secretion from the pancreas, which helps lower blood sugar levels
Key Benefits Observed: Significant weight loss: substantial and sustained reductions in body weight have been observed Appetite Suppression: satiety signals have been observed to spike, leading to vastly reduced caloric consumption
An Important Research Context The Unresolved Receptor Question DSIPs mechanism of action is, by the frank admission of the research field, partially unresolved
A peer-reviewed comprehensive review of Epitalons pharmacological and biological properties is available in a peer-reviewed overview of Epitalon as a highly bioactive pineal tetrapeptide with promising properties, summarizing medical, pharmacological, and biological research on the peptide